Ramesh Rengan

8.2k total citations · 1 hit paper
157 papers, 3.5k citations indexed

About

Ramesh Rengan is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Ramesh Rengan has authored 157 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Pulmonary and Respiratory Medicine, 56 papers in Radiology, Nuclear Medicine and Imaging and 53 papers in Radiation. Recurrent topics in Ramesh Rengan's work include Lung Cancer Diagnosis and Treatment (67 papers), Advanced Radiotherapy Techniques (52 papers) and Lung Cancer Treatments and Mutations (36 papers). Ramesh Rengan is often cited by papers focused on Lung Cancer Diagnosis and Treatment (67 papers), Advanced Radiotherapy Techniques (52 papers) and Lung Cancer Treatments and Mutations (36 papers). Ramesh Rengan collaborates with scholars based in United States, Netherlands and Canada. Ramesh Rengan's co-authors include Charles B. Simone, Jing Zeng, Jeffrey D. Bradley, George Rodrigues, Stephen M. Hahn, Suresh Senan, Sara Ramella, Marta Moreno, David A. Palma and Lawrence B. Marks and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ramesh Rengan

151 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis

2013 482 citations David A. Palma, Suresh Senan et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Ramesh Rengan

Since Specialization

Citations

This map shows the geographic impact of Ramesh Rengan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramesh Rengan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramesh Rengan more than expected).

Fields of papers citing papers by Ramesh Rengan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramesh Rengan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramesh Rengan. The network helps show where Ramesh Rengan may publish in the future.

Co-authorship network of co-authors of Ramesh Rengan

This figure shows the co-authorship network connecting the top 25 collaborators of Ramesh Rengan. A scholar is included among the top collaborators of Ramesh Rengan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramesh Rengan. Ramesh Rengan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review 2024 ·Future Oncology ·(unknown), (unknown), Evan Hall, Raquibul Hannan, Jay J. Liao, Alexander V. Louie, Ting Martin, Sarah P. Psutka, Ramesh Rengan, Shankar Siva, Anand Swaminath, Lisa Tachiki, Chad Tang, Bin S. Teh, Joseph Tsai, Scott S. Tykodi, Emily S. Weg, Nicholas G. Zaorsky, Simon S. Lo	4
2	Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics? 2022 ·Discover Oncology ·Hannah Thomas, Daniel S. Hippe, Parisa Forouzannezhad, (unknown), Paul E. Kinahan, Robert S. Miyaoka, Hubert Vesselle, Ramesh Rengan, Jing Zeng, Stephen R. Bowen	15
3	Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer 2021 ·The Journal of Alternative and Complementary Medicine ·(unknown), Ralph A. Pietrofesa, Evguenia Arguiri, Constantinos Koumenis, Steven J. Feigenberg, Charles B. Simone, Ramesh Rengan, Keith A. Cengel, William P. Levin, Melpo Christofidou‐Solomidou, Abigail T. Berman	6
4	A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes 2021 ·OncoImmunology ·Amit Maity, (unknown), Rosemarie Mick, Ramesh Rengan, Tara C. Mitchell, Ravi K. Amaravadi, Lynn M. Schuchter, Daniel A. Pryma, Dana Patsch, (unknown), (unknown), Andy J. Minn, Robert H. Vonderheide, John N. Lukens	18
5	Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), Smith Apisarnthanarax, Jing Zeng, George E. Laramore, Ramesh Rengan, Kenneth Russell, Jonathan J. Chen, William J. Ellis, George R. Schade, Jay J. Liao	22
6	Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer 2020 ·Physics in Medicine and Biology ·Chunyan Duan, W. Art Chaovalitwongse, (unknown), Daniel S. Hippe, Shouyi Wang, (unknown), Larry A. Pierce, Xiao Liu, (unknown), Robert S. Miyaoka, Hubert Vesselle, Paul E. Kinahan, Ramesh Rengan, Jing Zeng, Stephen R. Bowen	6
7	Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study 2020 ·Annals of Translational Medicine ·Jinfeng Huang, Jianfei Shen, Xiao Li, Ramesh Rengan, Nicola Silvestris, Minqi Wang, Lisa Derosa, Xuan-Qi Zheng, Andrea Belli, Xiaolei Zhang, Yan Michael Li, Aimin Wu	131
8	Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging 2019 ·Clinical Cancer Research ·Stephen R. Bowen, Daniel S. Hippe, W. Art Chaovalitwongse, Chunyan Duan, (unknown), Xiao Liu, Robert S. Miyaoka, Hubert Vesselle, Paul E. Kinahan, Ramesh Rengan, Jing Zeng	9
9	Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy 2019 ·British Journal of Radiology ·Hannah Thomas, Jing Zeng, (unknown), (unknown), Paul E. Kinahan, Robert S. Miyaoka, Hubert Vesselle, Ramesh Rengan, Stephen R. Bowen	15
10	Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging 2018 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Jing Zeng, Hubert Vesselle, Shilpen Patel, Ramesh Rengan, Stephen R. Bowen	18
11	Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location 2018 ·Clinical Lung Cancer ·Caitlin A. Schonewolf, (unknown), Abigail Doucette, Sunil Singhal, Melissa A. Frick, Eric Xanthopoulos, Michael N. Corradetti, Joseph S. Friedberg, Taine Pechet, John P. Christodouleas, William P. Levin, Abigail T. Berman, Keith A. Cengel, Vivek Verma, Stephen M. Hahn, John C. Kucharczuk, Ramesh Rengan, Charles B. Simone	30
12	Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated with Proton Therapy on the Proton Collaborative Group Prospective Registry Trial 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Shahed N. Badiyan, Pranshu Mohindra, Gary Larson, William F. Hartsell, H.K. Tsai, Jing Zeng, Ramesh Rengan, (unknown), Carlos Vargas, Steven J. Feigenberg, Charles B. Simone	1
13	First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non–Small-Cell Lung Cancer 2017 ·Clinical Lung Cancer ·Jill Remick, Caitlin A. Schonewolf, Peter Gabriel, Abigail Doucette, William P. Levin, John C. Kucharczuk, Sunil Singhal, Taine Pechet, Ramesh Rengan, Charles B. Simone, Abigail T. Berman	32
14	Is Intermediate Radiation Dose Escalation With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer Beneficial?: A Multi-institutional Propensity-Score Matched Analysis 2014 ·International Journal of Radiation OncologyBiologyPhysics ·George Rodrigues, Suresh Senan, Cary Oberije, Kayoko Tsujino, T. Wiersma, Marta Moreno, Tae Hyun Kim, Lawrence B. Marks, Ramesh Rengan, Luigi De Petris, Sara Ramella, Kim De Ruyck, Núria Rodríguez, A. Warner, Jeffrey D. Bradley, David A. Palma	2
15	Impact of sociodemographic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology Survey 2013 ·Practical Radiation Oncology ·Ramesh Rengan, (unknown), Jean B. Owen, Ritsuko Komaki, (unknown), J. Frank Wilson, Benjamin Movsas	3
16	Radiation Dosimetry and Biodistribution of the Hypoxia Tracer ¹⁸ F-EF5 in Oncologic Patients 2012 ·Cancer Biotherapy and Radiopharmaceuticals ·Lilie L. Lin, (unknown), James B. Stubbs, Ramesh Rengan, Sami Suilamo, Olof Solin, Chaitanya Divgi, Olli Eskola, Jonathan Sorger, Michael G. Stabin, Alexander V. Kachur, Stephen M. Hahn, Tove J. Grönroos, Sarita Forsbäck, Sydney M. Evans, Cameron J. Koch, Heikki Minn	16
17	Role of particle beam therapy in a trimodality approach to locally advanced non‐small cell lung cancer 2012 ·Thoracic Cancer ·Aparna H. Kesarwala, Surbhi Grover, Ramesh Rengan	2
18	A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response 2012 ·Journal of Thoracic Oncology ·Ramesh Rengan, Rosemarie Mick, Daniel A. Pryma, Mark Rosen, Lilie L. Lin, Amit Maity, Tracey L. Evans, James Stevenson, Corey J. Langer, John C. Kucharczuk, Joseph S. Friedberg, (unknown), Tiffany Sharkoski, Stephen M. Hahn	59
19	Integrating the Healthcare Enterprise in Radiation Oncology Plug and Play—The Future of Radiation Oncology? 2010 ·International Journal of Radiation OncologyBiologyPhysics ·May Abdel–Wahab, Ramesh Rengan, Bruce Curran, Stuart Swerdloff, (unknown), Colin Field, (unknown), Jatinder Palta, Prabhakar Tripuraneni	12
20	Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques 2009 ·Journal of Thoracic Oncology ·Christine E. Hill‐Kayser, Stephen Avery, Cristian Meșină, Paul D. James, Joseph S. Friedberg, Keith A. Cengel, Lilie L. Lin, Stephen M. Hahn, Ramesh Rengan	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact